tiprankstipranks
Trending News
More News >
FibroGen (FGEN)
NASDAQ:FGEN

FibroGen (FGEN) Stock Statistics & Valuation Metrics

Compare
1,043 Followers

Total Valuation

FibroGen has a market cap or net worth of $29.69M. The enterprise value is -$1.48M.
Market Cap$29.69M
Enterprise Value-$1.48M

Share Statistics

FibroGen has 101,043,970 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding101,043,970
Owned by Insiders1.78%
Owned by Institutions13.04%

Financial Efficiency

FibroGen’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is -184.87%.
Return on Equity (ROE)0.26
Return on Assets (ROA)-0.22
Return on Invested Capital (ROIC)-184.87%
Return on Capital Employed (ROCE)-1.85
Revenue Per Employee131.65K
Profits Per Employee-211.46K
Employee Count225
Asset Turnover0.14
Inventory Turnover4.93

Valuation Ratios

The current PE Ratio of FibroGen is -1.11. FibroGen’s PEG ratio is -0.04.
PE Ratio-1.11
PS Ratio0.00
PB Ratio-0.18
Price to Fair Value-0.29
Price to FCF-0.42
Price to Operating Cash Flow-0.42
PEG Ratio-0.04

Income Statement

In the last 12 months, FibroGen had revenue of 29.62M and earned -47.58M in profits. Earnings per share was -0.48.
Revenue29.62M
Gross Profit14.06M
Operating Income-150.42M
Pretax Income-153.37M
Net Income-47.58M
EBITDA-142.43M
Earnings Per Share (EPS)-0.48

Cash Flow

In the last 12 months, operating cash flow was -75.99M and capital expenditures -253.00K, giving a free cash flow of -76.25M billion.
Operating Cash Flow-75.99M
Free Cash Flow-76.25M
Free Cash Flow per Share-0.75

Dividends & Yields

FibroGen pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.44
52-Week Price Change-74.79%
50-Day Moving Average0.31
200-Day Moving Average0.39
Relative Strength Index (RSI)44.36
Average Volume (3m)657.00K

Important Dates

FibroGen upcoming earnings date is Aug 11, 2025, TBA Not Confirmed.
Last Earnings DateMay 12, 2025
Next Earnings DateAug 11, 2025
Ex-Dividend Date

Financial Position

FibroGen as a current ratio of 1.47, with Debt / Equity ratio of 0.00%
Current Ratio1.47
Quick Ratio1.45
Debt to Market Cap1.38
Net Debt to EBITDA-0.16
Interest Coverage Ratio-18.24

Taxes

In the past 12 months, FibroGen has paid -269.00K in taxes.
Income Tax-269.00K
Effective Tax Rate<0.01

Enterprise Valuation

FibroGen EV to EBITDA ratio is -0.53, with an EV/FCF ratio of -0.55.
EV to Sales2.55
EV to EBITDA-0.53
EV to Free Cash Flow-0.55
EV to Operating Cash Flow-0.55

Balance Sheet

FibroGen has $33.61M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$33.61M billion.
Cash & Marketable Securities$33.61M
Total Debt$0.00
Net Cash-$33.61M
Net Cash Per Share-$0.33
Tangible Book Value Per Share-$1.84

Margins

Gross margin is 57.78%, with operating margin of -507.80%, and net profit margin of -160.63%.
Gross Margin57.78%
Operating Margin-507.80%
Pretax Margin-517.76%
Net Profit Margin-160.63%
EBITDA Margin-480.83%
EBIT Margin-489.92%

Analyst Forecast

The average price target for FibroGen is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside3233.33% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-38.60%
EPS Growth Forecast95.86%

Scores

Smart Score6
AI Score46
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis